Picture of Harena Resources logo

HREE Harena Resources News Story

0.000.00%
gb flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapSucker Stock

REG - Harena Resources PLC - Annual Results and Notice of AGM

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251030:nRSd5673Fa&default-theme=true

RNS Number : 5673F  Harena Resources PLC  30 October 2025

30 October 2025

 

Harena Rare Earths Plc (formerly Harena Resources Plc)

 

("Harena" or the "Company")

 

Annual Results and Notice of AGM

 

Harena Rare Earths Plc (LSE: HREE), the rare earths company focused on the
Ampasindava ionic clay rare earth project in Madagascar (the "Ampasindava
Project"), announces its audited results for the 14-month period ended 30 June
2025 ("FY 2025") and gives notice of its 2025 Annual General Meeting (the
"AGM").

 

On 27 October 2025 the Company changed its name from Harena Resources Plc to
Harena Rare Earths Plc. Trading in the Company's shares under the new name
will take effect on the Main Market of the London Stock Exchange from 8.00
a.m. on 31 October 2025.

 

NOTICE OF AGM

 

The AGM will be held at the offices of Allenby Capital Limited, 5(th) floor, 5
St. Helen's Place, London, EC3A 6AB at 11:30 a.m. GMT on 4 December 2025.

 

A copy of the report and accounts for FY 2025, the Notice of AGM and related
forms of proxy will be posted to shareholders shortly and will also be
available on the Company's website at https://harenaresources.com/
(https://harenaresources.com/) and will also be available for inspection on
the National Storage Mechanism
at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

For further information please contact:

 

 Harena Rare Earths Plc

 Ivan Murphy, Executive Chairman                                +44 (0)20 7770 6424

 Allan Mulligan, Executive Technical Director

 Allenby Capital Limited - Financial Adviser & Broker           +44 (0)20 3328 5656

 Jeremy Porter / Vivek Bhardwaj (Corporate Finance)             info@allenbycapital.com (mailto:info@allenbycapital.com)

 Amrit Nahal / Kelly Gardiner (Sales & Corporate Broking)

 Celicourt Communications - Public Relations                    +44 (0)20 7770 6424   harena@celicourt.uk (mailto:harena@celicourt.uk)

 Mark Antelme / Charles Denley-Myerson

 

Notes to editors

Harena (www.harenaresources.com (http://www.harenaresources.com) ) is a rare
earths exploration and development company focused on the Ampasindava Ionic
Clay Rare Earth Project in Madagascar (Harena's interest is 100%). The project
hosts one of the largest ionic clay rare earth deposits outside of China, with
significant concentrations of high-value magnet metals, specifically heavy
rare earths, including neodymium (Nd), dysprosium (Dy), and praseodymium (Pr),
which are critical for the composition of neodymium magnets (NdFeB). Harena is
committed to low-impact, high recovery mining, providing a sustainable supply
of critical minerals for the global energy transition and military defence
industries as well as meeting the ever-growing demand for NdFeB from the
robotics sector.

CHAIRMAN'S STATEMENT

It gives me great pleasure to present this year's Annual Report and Accounts
for Harena Rare Earths PLC, marking a period of substantial progress and
growing momentum as we advance the Ampasindava Ionic Clay Rare Earth Project
(the "Project") in Madagascar towards production.

2025 has been a transformative year for the Company. In February 2025 the
Company completed the acquisition of Harena Resources Pty Ltd, the owner of
the Project and changed its name to Harena Resources PLC. On 27 October 2025
the Company changed its name from Harena Resources PLC to Harena Rare Earths
PLC.

Since then, we have advanced our globally significant 606,000 tonne TREO
JORC-compliant resource, which includes a premium mix of heavy rare earth
elements such as dysprosium, terbium, neodymium, and praseodymium, all
critical to the world's transition to clean energy, high-performance
technologies, and advanced defence systems.

Our Project is not an exploration play; it is a true mining project with a
clear development pathway. Following the completion of baseline metallurgical
test work and our Pre-Feasibility Study scheduled for November 2025, we will
move quickly into a Feasibility Study in early 2026. This will support the
conversion of our mining licence application, expected in 2026, as we continue
our active and constructive engagement with the Malagasy government and local
stakeholders.

A particularly important milestone in this period has been the strong
financial support we have secured from leading institutions in both the UK and
the US, including Wexford Capital, Fondren LLP, and RAB Capital. As a result
of these fundings, Harena is now financially secure to meet its near-term
costs, giving us the confidence and stability to accelerate the Project on its
path towards production.

In July 2025, the Company successfully completed a £1,231,500 institutional
placing to advance the Project, receiving strong support from both new and
existing investors and enabling progress on the Pre‑Feasibility Study,
environmental workstreams, and early-stage development activities.

Subsequently, in October 2025, the Company announced a further £450,000
strategic investment from RAB Capital and associates, increasing RAB's
shareholding to approximately 9%, via a convertible loan agreement where the
shares cannot be issued until January 2026. Led by Philip Richards, one of
London's most respected and long‑standing mining investors, RAB Capital has
a distinguished track record of identifying value and supporting growth in the
mining sector. This additional investment represents a strong endorsement of
our strategy and provides further financial strength as we continue to advance
our world-class ionic clay rare earth project toward production.

Harena occupies a truly unique position in the market. We are the only pure
ionic clay rare earth company listed on the London Stock Exchange, offering
one of the very few large-scale ionic clay deposits outside China. This
positions us as a vital strategic partner in strengthening resilient,
transparent, and geopolitically neutral supply chains for critical rare earth
elements.

The U.S. Government has made clear its determination to secure critical
mineral supply chains and reduce reliance on China for rare earth elements.
Harena is exceptionally well placed to be part of this solution, with a
development-ready, ex-China ionic clay deposit that can deliver the heavy rare
earths essential for defence, energy, and technology applications. It is our
stated strategy to increase our engagement with U.S. government agencies as we
move towards production.

In line with this strategy, we are also advancing an OTC cross-trade of our
shares in the United States. This represents the first step in opening access
to U.S. capital markets and enabling American investors to participate
directly in the Group's growth, while continuing to trade on the London Stock
Exchange.

Looking ahead, we expect 2026 to be another pivotal year. Completion of our
Feasibility Study, the expected upgrade of our licence, and ongoing progress
with our government and community partnerships will continue to de-risk and
advance the Project. From 2027 onwards, we will transition towards project
financing, construction, and ultimately, first concentrate shipments targeted
for 2028.

On behalf of the Board, I would like to thank our shareholders, partners, and
stakeholders for their continued support. With the financial backing now in
place, a globally significant resource, and a motivated and experienced
management team, Harena is exceptionally well positioned to deliver long-term
value and to play a crucial role in securing the future of critical mineral
supply chains.

 

Ivan James Bowen Murphy

Executive Chairman

30 October 2025

 

FINANCIAL STATEMENTS (THE NOTES ARE AVAILABLE IN THE REPORT AND ACCOUNTS FOR
FY 2025)

 

Consolidated Statement of Comprehensive Income for the period ended 30 June
2025

 

                                                                                   Year ended 30 June 2025  Year ended

                                                                                                            30 June 2024
                                                                            Notes  £                        £

 Administrative fees and other expenses                                     5      (3,330,754)              (1,127,356)
 Operating loss                                                                    (3,330,754)              (1,127,356)

 Finance income                                                                    112                      2,202
 Listing costs                                                              12     (10,321,369)             -
 Finance costs                                                              9      (535,277)                (813,639)
 Loss before tax                                                                   (14,187,288)             (1,938,793)

 Income tax                                                                 11     -                        -

 Loss after tax for the year attributable to owners of the parent                  (14,187,288)             (1,938,793)

 Other comprehensive income
 Items that may be reclassified to profit or loss:
 Exchange differences on translation of foreign operations                         48,777                   (25,598)

 Total comprehensive loss for the year                                             (14,138,511)             (1,964,391)

 Total comprehensive loss attributable to owners of Harena Rare Earths PLC         (14,138,511)             (1,964,391)
 Total comprehensive loss attributable to non-controlling interests                -                        -
 Total comprehensive loss for the period                                           (14,138,511)             (1,964,391)

 Basic and diluted loss per share (pence)                                   15     (10.78)                  (1.65)

 

Consolidated Statement of Financial Position as at 30 June 2025

                                   Notes  30 June 2025  30 June 2024
                                          £             £

 Non-current assets
 Other intangible asset            14     1,875,768     1,905,744
 Total non-current assets                 1,875,768     1,905,744

 Current assets
 Trade and other receivables       18     196,289       40,926
 Cash and cash equivalents                28,425        45,442
 Total current assets                     224,714       86,368

 Total assets                             2,100,482     1,992,112

 Current liabilities
 Trade and other payables          19     612,314       986,111
 Total current liabilities                612,314       986,111

 Non-current liabilities
 Loan note liability               20     572,937       -
 Convertible loan note             20     -             2,637,200
 Total non-current liabilities            572,937       2,637,200

 Total liabilities                        1,185,251     3,623,311

 Net assets/(liabilities)                 915,231       (1,631,199)

 Equity
 Share capital                     21     2,033,422     548,538
 Share premium                     21     9,619,057     -
 Treasury shares                   21     36,000
 Share option and warrant reserve  22     922,324       -
 Share based payment reserve       22     1,831,310     -
 Translation reserve               21     23,179        (25,598)
 Retained earnings                        (6,284,822)   (2,637,950)
 Reserve acquisition reserve       21     (7,611,916)   -
 Non-controlling Interest                 346,677       346,677
 Pre-acquisition reserve                  -             137,134
 Total equity                             915,231       (1,631,199)

 

 

 

The financial statements were approved and authorised for issue by the Board
of Directors on 30 October 2025 and were signed on its behalf by:

 

 

Ivan James Bowen
Murphy                                 Andrew
Paul Richards

Executive
Chairman
Non-Executive Director

 

            Company Registration No.12557958

Company Statement of Financial Position as at 30 June 2025

                                   Notes  30 June 2025  30 June 2024
                                          £             £

 Non-current assets
 Investment in subsidiary          16     10,000,000    -
 Loan to subsidiary                17     1,049,556     -
 Total non-current assets                 11,049,556    -

 Current assets
 Trade and other receivables       18     168,816       8,520
 Cash and cash equivalents                1,991         33,971
 Total current assets                     170,807       42,491

 Total assets                             11,220,363    42,491

 Current liabilities
 Trade and other payables          19     281,328       141,636
 Total current liabilities                281,328       141,636

 Non-current liabilities
 Loan note liability               20     608,725       -
 Total non-current liabilities            608,725       -

 Total liabilities                        890,053       141,636

 Net assets/(liabilities)                 10,330,310    (99,145)

 Equity
 Share capital                     21     2,033,422     216,250
 Share premium                     21     9,619,057     921,797
 Treasury shares                   21     36,000        -
 Share option and warrant reserve  22     989,127       17,422
 Share based payment               22     1,831,310     -
 Retained earnings                        (4,178,606)   (1,254,614)
 Total equity                             10,330,310    (99,145)

 

 

The Company has taken advantage of the exemption allowed under section 408 of
the Companies Act 2006 and has not presented its own Statement of
Comprehensive Income in these financial statements. The loss after tax of the
Company for the year was £2,941,414 (2024: loss of £392,022).

 

The financial statements were approved and authorised for issue by the Board
of Directors on 30 October 2025 and were signed on its behalf by:

 

 

 

Ivan James Bowen
Murphy                                 Andrew
Paul Richards

Executive
Chairman
Non-Executive Director

 

            Company Registration No.12557958

Consolidated Statement of Changes in Equity for the year ended 30 June 2025

                                                            Share capital  Share premium  Treasury shares  Share option & warrant reserve      Share based payment reserve  Translation reserve  Reverse acquisition reserve  Pre-acquisition reserve  Retained earnings  Total Equity of owners    Non-controlling interest  Total equity

                                                            £              £              £                £                                   £                            £                    £                            £                        £                  £                         £                         £
 Balance as at 30 June 2023                                 548,538        -              -                -                                   -                            -                    -                            63,293                   (699,157)          (87,326)                  346,677                   259,351

 Loss for the period                                        -              -              -                -                                   -                            -                    -                            -                        (1,938,793)        (1,938,793)               -                         (1,938,793)
 Exchange differences on translation of foreign operations  -              -                               -                                   -                            (25,598)             -                            -                        -                  (25,598)                  -                         (25,598)
 Total comprehensive loss                                   -              -              -                -                                   -                            (25,598)             -                            -                        (1,938,793)        (1,964,391)               -                         (1,964,391)
 Issue of performance rights                                -              -              -                -                                   -                            -                    -                            73,841                   -                  73,841                    -                         73,841
 Balance as at 30 June 2024                                 548,538        -              -                -                                   -                            (25,598)             -                            137,134                  (2,637,950)        (1,977,876)               346,677                   (1,631,199)

 Loss for the period                                        -              -              -                -                                   -                            -                    -                            -                        (14,187,288)       (14,187,288)              -                         (14,187,288)
 Exchange differences on translation of foreign operations  -              -              -                -                                   -                            48,777               -                            -                        -                  48,777                    -                         48,777
 Total comprehensive loss                                   -              -                               -                                   -                            48,777               -                            -                        (14,187,288)       (14,138,511)              -                         (14,138,511)

 Transactions with owners
 New shares issued (note 21)                                1,817,172      8,745,700      36,000           -                                   -                            -                    -                            -                        -                  10,598,872                -                         10,598,872
 FV adjustment (note 21)                                    -              (35,940)       -                -                                   -                            -                    -                            -                        -                  (35,940)                  -                         (35,940)
 Share issue costs (note 21)                                -              (12,500)       -                -                                   -                            -                    -                            -                        -                  (12,500)                  -                         (12,500)
 Share based payment charge (note 22)                       -              -              -                922,324                             1,831,310                    -                    -                            -                        -                  2,753,634                 -                         2,753,634
 Settlement of subsidiary loan notes                        -              -              -                -                                   -                            -                    -                            3,044,105                -                  3,044,105                 -                         3,044,105
 Reverse acquisition adjustments                            (332,288)      921,797        -                -                                   -                            -                    (7,611,916)                  (3,181,239)              10,540,416         336,770                   -                         336,770
 Total transactions with owners                             1,484,884      9,619,057      36,000           922,324                             1,831,310                    -                    (7,611,916)                  (137,134)                10,540,416         16,684,941                -                         16,684,941
 Balance as at 30 June 2025                                 2,033,422      9,619,057      36,000           922,324                             1,831,310                    23,179               (7,611,916)                  -                        (6,284,822)        568,554                   346,677                   915,231

 

The nature of the share option and warrant reserve, share base payment
reserve, translation reserve and reverse acquisition reserves are described in
note 21.

 

Company Statement of Changes in Equity for the period ended 30 June 2025

                                       Share      Share premium                    Share option & warrant reserve      Share based payment reserve  Retained earnings  Total

                                       capital                   Treasury shares                                                                                        equity
                                       £          £              £                 £                                   £                            £                  £
 Balance as at 30 April 2023           216,250    921,797        -                 17,422                              -                            (862,592)          292,877

 Loss for the period                   -          -              -                 -                                   -                            (392,022)          (392,022)
 Total comprehensive loss              -          -              -                 -                                   -                            (392,022)          (392,022)

 Balance as at 30 April 2024           216,250    921,797        -                 17,422                              -                            (1,254,614)        (99,145)

 Loss for the period                   -          -              -                 -                                   -                            (2,941,414)        (2,941,414)
 Total comprehensive income            -          -              -                 -                                   -                            (2,941,414)        (2,941,414)

 Transactions with owners
 New shares issued (note 21)           1,817,172  8,745,700      36,000            -                                   -                            -                  10,598,872
 FV adjustment (note 21)                          (35,940)       -                                                                                                     (35,940)
 Share issue costs (note 21)           -          (12,500)       -                 -                                   -                            -                  (12,500)
 Share based payment charge (note 22)  -          -              -                 989,127                             1,831,310                    -                  2,820,437
 Lapsed warrants                       -          -              -                 (17,422)                            -                            17,422             -
 Total transaction with owners         1,817,172  8,697,260      36,000            971,705                             1,831,310                    17,422             13,370,869

 Balance as at 30 June 2025            2,033,422  9,619,057      36,000            989,127                             1,831,310                    (4,178,606)        10,330,310

 

              Consolidated Statement of Cash Flows for the year ended
30 June 2025

                                                              Notes  Year ended     Year ended

                                                                     30 June 2025   30 June 2024
                                                                     £              £
 Operating activities
 Loss after tax                                                      (14,187,288)   (1,938,793)
 Adjustments for:
 Finance costs                                                9      535,277        785,732
 Share based payment expense                                  22     2,125,220      179,596
 Listing costs                                                       10,321,369     -
 Share capital issued in exchange for costs                          1,119,030      -
 Changes in working capital:
 (Increase)/decrease in trade and other receivables           18     (155,363)      155,700
 Increase in trade and other payables                         19     19,352         72,985
 Net cash outflow from operating activities                          (222,403)      (744,780)

 Cash flow from investing activities
 Investment in exploration assets                             14     (151,637)      (198,623)
 Net cash outflow from investing activities                          (151,637)      (198,623)

 Cash flow from financing activities
 Proceeds from shares issued                                  21     80,311         -
 Finance costs                                                9      (524,790)      (312,258)
 Convertible loan notes issued                                       -              1,059,353
 Convertible loan notes redeemed                                     -              (575,226)
 Loan note proceeds                                           20     752,725        -
 Net cash inflow from financing activities                           308,246        171,869

 Decrease in cash and cash equivalents                               (65,794)       (771,534)

 Cash and cash equivalents as at the beginning of the period         45,442         816,384
 Foreign exchange on cash and cash equivalent                        48,777         592
 Cash and cash equivalents at the end of period                      28,425         45,442

 

 Net debt reconciliation  Cash at bank  Loan note   Convertible loan note  Total

                          and in hand   liability
                          £             £           £                      £
 At 1 July 2023           816,384       -           (2,146,681)            (1,330,297)
 Cash flows               (771,534)     -           (484,127)              (1,255,661)
 Non-cash charges         592           -           (6,392)                (5,800)
 As 30 June 2024          45,442        -           (2,637,200)            (2,591,758)

 As 1 July 2024           45,442        -           (2,637,200)            (2,591,758)
 Cash flows               (65,794)      -           -                      (65,794)
 Non-cash charges         48,777        (572,937)   2,637,200              2,113,040
 As 30 June 2025          28,425        (572,937)   -                      (544,512)

 

During the year, the Company issued share options and warrants. These
transactions did not involve any cash outflows and are therefore excluded from
the statement of cash flows. The fair value of the share-based payments is
disclosed in note 22.

Company Statement of Cash Flows for the period ended 30 June 2025

                                                              Notes  Period ended   Year ended

                                                                     30 June 2025   30 April 2024

                                                                     £              £
 Operating activities
 Loss after tax                                                      (2,941,414)    (392,022)
 Adjustments for:
 Impairment of loan                                                  -              249,341
 Share based payment expense                                  22     2,132,655      -
 Share capital issued in exchange for costs                          577,751        -

 Changes in working capital
 Decrease in trade and other receivables                      18     (160,297)      (520)
 Increase in trade and other payables                         19     319,325        22,414
 Net cash outflow from operating activities                          (71,980)       (120,787)

 Cash flow from financing activities
 Proceeds from shares issued                                  21     40,000         -
 Net cash inflow from financing activities                           40,000         -

 Decrease in cash and cash equivalents                               (31,980)       (120,787)

 Cash and cash equivalents as at the beginning of the period         33,971         154,758

 Cash and cash equivalents at the end of period                      1,991          33,971

 

During the year, the Company issued share options and warrants. These
transactions did not involve any cash outflows and are therefore excluded from
the statement of cash flows. The fair value of the share-based payments is
disclosed in note 22.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FR FDLFMSEISESS



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Harena Resources

See all news